BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


March Archive 2004 - have your press release here?

Agilent Technologies Introduces Ion Trap Mass Spectrometer with 4x Improvement in Sensitivity

Biotech Tracker: SGN-40 for Multiple Myeloma

Vernalis plc: preliminary results for the eight months ended 31 December 2003

Vernalis regains control of North American rights to frovatriptan from Elan

DailyUpdates - breaking journal and press release articles for the drug development sector

Syncroscopy - New 3-D Imaging Software Makes Leading Technology Affordable for All Microscopists

Merck & Co develop new leads for the treatment of bipolar disorder through the development of a new HTS assay of inositol monophosphatase inhibitors 

SWITCH Biotech AG Joint Forces Against Vitiligo

ASINEX and SIENABIOTECH announce Lead Generation Collaboration

Sulfonylureas vs thiazolidinediones for the prevention of diabetic nephropathy

Cytomyx Licenses Cancer Database To Astrazeneca

Frank Morich joins Innate Pharma's board of directors

Biotech Tracker: Antibody Drugs from PDLI Advance

Biotech Tracker: Gene Therapy Trial for Rheumatoid Arthritis Underway

New data published on KW-7158, a novel treatment of overactive bladder

Inpharmatica Announces Biopendium Online [TM] Subscription Agreement with Taisho of Japan

Oxford Biomedica awarded £0.5 million from the UK department of health gene therapy research programme

NMDA receptor antagonism limits visceral hypersensitivity and may offer an approach to functional gut disorders

Shire Pharmaceuticals boosted by first Fosrenol approval

MUNICH BIOTECH REPORTS ADDITIONAL POSITIVE DATA FROM MBT- 0206 PHASE I TRIAL

NextGen Sciences announces distribution agreement with SCRUM Inc. in Japan

Lynx and Solexa Jointly Acquire DNA Technology Assets

Researchers report the efficacy of the bisphosphonate, YM529 in preclinical rheumatoid arthritis studies

Agilent Technologies Upgrades Software for Mass Spectrometry-Based Proteomics Research

Researchers report that controlling intracellular calcium levels may offer a new dual approach to hypertension and diabetes

CHI's Portfolio Management, Project Management, Strategic Planning, Drug Discovery R&D and Knowledge Management

Biotech Tracker: Orphan for Exelixis

Biotech Tracker: Zenapax (Daclizumab) for Asthma 

Beta-O2 completes $2 million seed round led by Vitalife

New research supports switching from to exemestane after two to three years of tamoxifen therapy in women with primary breast cancer

Siegfried delivers solid results

Syngene - New Imaging System has World Premier On Syngene Stand 461 at Analytica 

Inpharmatica announces ADME technology agreement with GlaxoSmithKline

Capsulution NanoScience AG Diagnostic Particle Expert Appointed to Advisory Board

New Medical Director at SOLVO Biotechnology

Bionest Partners appoints senior consultant in corporate finance and strategic consulting

Boehringer Ingelheim Researchers develop new therapeutics for the treatment of chronic hepatitis C infection

DNA Research Innovation Ltd. Announces OEM Agreement with Isohelix Ltd

Biotech Tracker: Riquent Still Has Hurdles to Overcome

Biotech Tracker: E.U. to Review Inhaled Insulin Approval Application

Cytokine targeting of dendritic cells to tumors produces dramatic anti-cancer activity

Respiratory Syncytial Virus: Can antivirals make the grade?

DVC Deutsche Venture Capital strengthens its management team in the technology field

AMT Amsterdam Molecular Therapeutics (AMT) Obtains Orphan Drug Designation for its LPL Gene Therapy Product

Potential of ghrelin receptor ligands in the treatment of cardiovascular disease

New Contract Research Organization (CRO) Special Report Reveals 10 Ways To Make Better Hires Faster

GANYMED Pharmaceuticals AG and the University of Rotterdam Establish new Cooperation

Biotech Tracker: TKT’s I2S Trial Moving Forward

Biotech Tracker: Risk of Adversities with Stem Cells Therapy in the Heart

Granulocyte colony-stimulating factor (G-CSF) as a new therapeutic approach to myocardial infarction.

Synbiosis: New Motorised Stage for Automated Zone Reader - Guarantees Rapid Analysis of Bioassay Plates

Enhanced Epilepsy Therapy with Genetic Analysis

COBRA SIGNS AGREEMENT TO MANUFACTURE AVIDEX' FIRST MONOCLONAL T CELL RECEPTORS

Neuropathic Pain: Pfizer attempting to hold on to market leadership

Yale researchers discover a role for Kv1.3 potassium channels in the etiology of diabetes as well as obesity

Syngene - New Chemiluminescence Image Analyser Guarantees High Resolution for Greater Accuracy

Biotech Tracker: Revlimid Orphaned Again

NextGen Sciences attracts new investors and builds its Board of Directors

OSI pharmaceuticals report on the pharmacokinetics, safety and efficacy of their anticancer thymidylate synthase inhibitor, OSI-7904L

Comments on GM Foods: evaluating the Farm Scale Trials: report of the Environmental Audit Committee of 2 March 2004

PIPELINE 2004: PORTFOLIO STRATEGY CONGRESS FEATURES TOP 25 PHARMA, BIOTECHS, WALL STREET AND VENTURE CAPITAL THROUGH 4 TRACKS AND 80+ SPEAKERS 

Flinder Medical Centre researchers discover the cause of diabetic gastrointestinal dysfunction

GM CROP TRIALS COULD POSE THREAT TO LAND VALUES

abc welcomes Government approval of GM crops 

Overexpression of malonyl-coenzyme A (CoA) decarboxylase as a novel therapeutic approach to insulin resistance

Agilent Technologies Announces 50,000th Shipment of Its Industry-Leading Liquid Chromatography System

Cambridge Consultants - Encouraging Signs in UK Technology Markets

Global Life Science Ventures announces investment into CareX

New data confirm that Fujisawa Pharmaceuticals' poly (ADP-ribose) polymerase-1 (PARP-1) inhibitor FR255595 limits neural damage in models of Parkinson's disease

BioTech Stock Report: An Ounce of Prevention - Vaccines

GREENPEACE AND MILK - THE FACTS on GM Animal Feed

Biotech Tracker: Inhaled Cystic Fibrosis Therapy Data Encouraging

Biotech Tracker: SGN-30 is an Orphan, but May Lose Out to Sister Construct

Fungal infections: From specialty area to expanded population

Adiponectin limits tumor angiogenesis-the missing link between obesity and increased risk of developing cancer?

JPK Instruments Opens Door to Japanese Market Distribution Agreement Signed With the TOYO Corporation

Agilent Technologies Combines Gene Expression, Proteomics and Reagents Businesses into New Life-Sciences Unit

Agilent Technologies Introduces LC System for Proteomics that Combines Micro Collection and Spotting Capabilities

BioPortfolio: BioOncology 2004, European Hospital Register, 2:1 Job Adverts

Oxford Biomedica Plc: Preliminary Results For The Year Ended 31 December 2003

Japanese researchers identify Interleukin-5 (IL-5) receptors as a target for preventing airway remodelling in asthma 

Biotech Tracker: Thalomid: What’s in a Label?

Biotech Tracker: Neuroimmunophilin Ligands Still Need to Demonstrate Therapeutic Effect

SCYNEXIS signs a drug discovery deal with Mitsubishi Pharma

Oxxon Pharmaccines Appoints Frank Malinoski MD PhD as Chief Medical Officer

Biotech Tracker: Phenoptin Trial Underway

Biotech Tracker: Setback for Cortex’s Ampakine Program

University of Texas Medical Branch researchers publish key data on respiratory syncytial virus infection

Richard A. Lerner, M.D., President Of The Scripps Research Institute, To Lead Dyadic Scientific Advisory Board

Montalier International Ltd., a leading international partnering consultancy and conference acquires Tri-Med Pharmaceuticals 

HRT declared unsuitable for first line osteoporosis prevention

Inpharmatica selects MDL to distribute Biopendium worldwide

Veteran Executive Richard Soltero To Head PharmaDirections

 

BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive

 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.